McDougle CJ, Naylor ST, Cohen DJ et al. (1996), A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53(11):1001-1008 [see comments].
McDougle CJ, Stigler KA, Posey DJ (2003), Treatment of aggression in children and adolescents with autism and conduct disorder. J Clin Psychiatry 64(suppl 4):16-25.
McGee GG, Morrier MJ, Daly T (1999), An incidental teaching approach to early intervention for toddlers with autism. Journal of the Association for Persons with Severe Handicaps 24(3):133-146.
Posey DJ, McDougle CJ, Aman MG et al. (2004a), A randomized, double-blind, placebo-controlled, crossover trial of methylphenidate in children with hyperactivity associated with pervasive developmental disorders. Neuropsychopharmacology 29(suppl 1):S142.
Posey DJ, Puntney JI, Sasher TM et al. (2004b), Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 14(2):233-241.
Schreibman L (2000), Intensive behavioral/psychoeducational treatments for autism: research needs and future directions. J Autism Dev Disord 30(5):373-378.
Shea S, Turgay A, Carroll A et al. (2004), Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114(5):634-641.
Stigler KA, Posey DJ, McDougle CJ (2004), Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol 14(3):455-463.
